Fidelity Advisor Biotechnology A (FBTAX)

Fund Assets	2.20B
Expense Ratio	0.96%
Min. Investment	$0.00
Turnover	51.00%
Dividend (ttm)	0.54
Dividend Yield	1.07%
Dividend Growth	-66.67%
Payout Frequency	Annual
Ex-Dividend Date	n/a

Previous Close	48.45
YTD Return	29.41%
1-Year Return	63.63%
5-Year Return	77.62%
52-Week Low	29.46
52-Week High	48.45
Beta (5Y)	0.85
Holdings	112
Inception Date	Dec 27, 2000

About FBTAX

The investment seeks capital appreciation. The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.

• Fund Family: Fidelity
• Category: Health
• Performance Rating: High
• Risk Rating: Above Average
• Stock Exchange: NASDAQ
• Ticker Symbol: FBTAX
• Share Class: Class A
• Index: S&P 500 TR

Performance

FBTAX had a total return of 63.63% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.80%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
FIJYX	Class Z	0.58%
FBTIX	Class I	0.71%
FBTTX	Class M	1.21%
FBTCX	Class C	1.71%

Top 10 Holdings

47.84% of assets

Name	Symbol	Weight
AbbVie Inc.	ABBV	14.74%
Gilead Sciences, Inc.	GILD	5.55%
Alnylam Pharmaceuticals, Inc.	ALNY	4.64%
Spyre Therapeutics, Inc.	SYRE	3.46%
Insmed Incorporated	INSM	3.29%
Ascendis Pharma A/S	ASND	3.26%
argenx SE	ARGX	3.25%
Dianthus Therapeutics, Inc.	DNTH	3.23%
Cogent Biosciences, Inc.	COGT	3.22%
Oruka Therapeutics, Inc.	ORKA	3.19%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 26, 2025	$0.544	Dec 29, 2025
Dec 26, 2024	$1.632	Dec 27, 2024
Dec 21, 2023	$0.315	Dec 22, 2023
Dec 17, 2021	$5.364	Dec 20, 2021
Jul 9, 2021	$0.103	Jul 12, 2021
Dec 18, 2020	$2.840	Dec 21, 2020

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Aug 19, 2026

Data Sources Report a data error